Pharmacy News December 2018 | Page 31

Dec 2018 F Feature strand breaks cause upregulation of p53 as a tumour suppressor gene,” he says. “CRISPR- mediated DNA cuts were expected to do the same. “However, what it does show is that CRISPR manipulated cells should be tested extensively before using them in the lab or injecting them back into patients.” In a rapidly expanding field, such cautionary practice is prudent within adaptive regulatory frameworks. However, reaction to research on human embryos in the US, China, Sweden and the UK has been met with predictable resistance. For Dr Simon Longstaff, executive director of the Ethics Centre, an independent not-for-profit organisation in Sydney, the pace of technological development can remove the chance for society to self-regulate, as has happened with previous movements towards eugenics. “CRISPR puts into the hands of those who would like to do this the tools which enable it to be achieved with a greater degree of precision and ease,” he says. “When that kind of power becomes available, it falls into a category where a general maxim ought to be observed. And that is that if you divorce technical mastery from ethical restraint it becomes the root of all tyranny. “The friction by which society can adjust is removed by tools of this kind, unless those tools are carefully developed, handled and released. “The point is not to say that it should never be used, or that it’s always going to be used in detrimental ways, it’s really to say there are certainly issues that need to be acknowledged — and some within the science community do that.” Professor Crossley recognises the need to advance cautiously, particularly with gene drive technology, such as the eradication of disease-carrying species of mosquito. Indeed, the review of the Gene Technology Regulations proposes increased regulatory oversight of laboratory research with gene drive GMOs, and would require case-by-case assessment and a licence from the regulator before research proceeds. “You wouldn’t want to destroy the species of mosquito that pollinated something like cucumbers,” says Professor Crossley. “What happens if that jumping gene gets mutated? At what speed does it spread through the population? “But designer babies aren’t the immediate issue and could be a distraction. The technology is still extraordinarily complicated and, if someone wanted to design a baby and approached a scientist to do it, what would they ask? “We don’t know the right gene to put in for intelligence, the right gene for beauty, or the right gene for happiness.” “Dolly the sheep was cloned 20 years ago but there have been no examples of human cloning, and why would there be? It’s too complicated, takes too long, and the gains are too uncertain.” Professor Merlin Crossley If you want a blonde-haired child, he says, it’s much easier to dye their hair blonde. “It has been possible to modify embryos for many years but it’s highly regulated,” he says. “Dolly the sheep was cloned 20 years ago but there have been no examples of human cloning, and why would there be? It’s too complicated, takes too long, and the gains are too uncertain.” References: 1. Scientifi c Reports 2018; online 17 May. 2. Nature Medicine 2018; 24:927-30. 3. Nature Medicine 2018; 24:939-46. Comment online www.pharmacynews.com.au 31